A multidisciplinary approach to soft-tissue sarcoma of the extremities

References

• Gatta G, van der Zwan JM, Casali PG, et al. Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer. 2011;47(17):2493–2511. .
   PubMed Web of Science ®Google Scholar
• Gatta G, Capocaccia R, Botta L, et al. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. Lancet Oncol. 2017;18(8):1022–1039. .
   PubMed Web of Science ®Google Scholar
• Penel N, Coindre JM, Giraud A, et al. Presentation and outcome of frequent and rare sarcoma histologic subtypes: A study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centers. Cancer. 2018;124(6):1179–1187. .
   PubMed Web of Science ®Google Scholar
• Pisters PW, Leung DH, Woodruff J, et al. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996;14(5):1679–1689.
   PubMed Web of Science ®Google Scholar
• Kaatsch P. Epidemiology of childhood cancer. Cancer Treat Rev. 2010;36(4):277–285.
   PubMed Web of Science ®Google Scholar
• Ng VY, Scharschmidt TJ, Mayerson JL, et al. Incidence and survival in sarcoma in the United States: a focus on musculoskeletal lesions. Anticancer Res. 2013;33(6):2597–2604.
   PubMed Web of Science ®Google Scholar
• Aben KK, van Gaal C, van Gils NA, et al. Cancer in adolescents and young adults (15-29 years): a population-based study in the Netherlands 1989-2009. Acta Oncol. 2012;51(7):922–933.
   PubMed Web of Science ®Google Scholar
• Harms D. Alveolar rhabdomyosarcoma: a prognostically unfavorable rhabdomyosarcoma type and its necessary distinction from embryonal rhabdomyosarcoma. Curr Top Pathol. 1995;89:273–296. .
   PubMedGoogle Scholar
• Arnold MA, Anderson JR, Gastier-Foster JM, et al. Histology, fusion status, and outcome in alveolar rhabdomyosarcoma with low-risk clinical features: a report from the children’s oncology group. Pediatr Blood Cancer. 2016;63(4):634–639. .
   PubMed Web of Science ®Google Scholar
• Arnold MA, Barr FG. Molecular diagnostics in the management of rhabdomyosarcoma. Expert Rev Mol Diagn. 2017;17(2):189–194.
   PubMed Web of Science ®Google Scholar
• Barr FG, Galili N, Holick J, et al. Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat Genet. 1993;3(2):113–117.
   PubMed Web of Science ®Google Scholar
• Galili N, Davis RJ, Fredericks WJ, et al. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat Genet. 1993;5(3):230–235. .
   PubMed Web of Science ®Google Scholar
• Duan F, Smith LM, Gustafson DM, et al. Genomic and clinical analysis of fusion gene amplification in rhabdomyosarcoma: a report from the Children’s Oncology Group. Genes Chromosomes Cancer. 2012;51(7):662–674. .
   PubMed Web of Science ®Google Scholar
• Oberlin O, Rey A, Lyden E, et al. Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups. J Clin Oncol. 2008;26(14):2384–2389. .
   PubMed Web of Science ®Google Scholar
• Sultan I, Ferrari A. Selecting multimodal therapy for rhabdomyosarcoma. Expert Rev Anticancer Ther. 2010;10(8):1285–1301.
   PubMed Web of Science ®Google Scholar
• Hawkins DS, Gupta AA, Rudzinski ER. What is new in the biology and treatment of pediatric rhabdomyosarcoma? Curr Opin Pediatr. 2014;26(1):50–56.
   PubMed Web of Science ®Google Scholar
• Skapek SX, Ferrari A, Gupta AA, et al. Rhabdomyosarcoma. Nat Rev Dis Primers. 2019;5(1):1.
   PubMed Web of Science ®Google Scholar
• Sultan I, Rodriguez-Galindo C, Saab R, et al. Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005: an analysis of 1268 patients. Cancer. 2009;115(15):3537–3547.
   PubMed Web of Science ®Google Scholar
• Kilpatrick SE, Doyon J, Choong PF, et al. The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases. Cancer. 1996;77(8):1450–1458.
   PubMed Web of Science ®Google Scholar
• Hoffman A, Ghadimi MP, Demicco EG, et al. Localized and metastatic myxoid/round cell liposarcoma: clinical and molecular observations. Cancer. 2013;119(10):1868–1877. .
   PubMed Web of Science ®Google Scholar
• Huh WW, Yuen C, Munsell M, et al. Liposarcoma in children and young adults: a multi-institutional experience. Pediatr Blood Cancer. 2011;57(7):1142–1146. .
   PubMed Web of Science ®Google Scholar
• Alaggio R, Coffin CM, Weiss SW, et al. Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age. Am J Surg Pathol. 2009;33(5):645–658. .
   PubMed Web of Science ®Google Scholar
• Crozat A, Aman P, Mandahl N, et al. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature. 1993;363(6430):640–644.
   PubMed Web of Science ®Google Scholar
• Rabbitts TH, Forster A, Larson R, et al. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet. 1993;4(2):175–180.
   PubMed Web of Science ®Google Scholar
• van der Graaf WTA, Orbach D, Judson IR, et al. Soft tissue sarcomas in adolescents and young adults: a comparison with their paediatric and adult counterparts. Lancet Oncol. 2017;18(3):e166–e175.
   PubMed Web of Science ®Google Scholar
• Gingrich AA, Bateni SB, Monjazeb AM, et al. Extremity soft tissue sarcoma in the elderly: are we overtreating or undertreating this potentially vulnerable patient population? J Surg Oncol. 2019;119(8):1087–1098. .
   PubMed Web of Science ®Google Scholar
• Mutter RW, Singer S, Zhang Z, et al. The enigma of myxofibrosarcoma of the extremity. Cancer. 2012;118(2):518–527.
   PubMed Web of Science ®Google Scholar
• Mentzel T, Calonje E, Wadden C, et al. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol. 1996;20(4):391–405. .
   PubMed Web of Science ®Google Scholar
• Huang HY, Lal P, Qin J, et al. Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems. Hum Pathol. 2004;35(5):612–621.
   PubMed Web of Science ®Google Scholar
• Antonescu CR. The role of genetic testing in soft tissue sarcoma. Histopathology. 2006;48(1):13–21.
   PubMed Web of Science ®Google Scholar
• Dean BJF, Branford-White H, Giele H, et al. Management and outcome of acral soft-tissue sarcomas. Bone Joint J. 2018;100-B(11):1518–1523. .
   PubMed Web of Science ®Google Scholar
• Pradhan A, Cheung YC, Grimer RJ, et al. Soft-tissue sarcomas of the hand: oncological outcome and prognostic factors. J Bone Joint Surg Br. 2008;90(2):209–214. .
   PubMedGoogle Scholar
• Kawai A, Hosono A, Nakayama R, et al. Clear cell sarcoma of tendons and aponeuroses: a study of 75 patients. Cancer. 2007;109(1):109–116. .
   PubMed Web of Science ®Google Scholar
• Cribb GL, Loo SC, Dickinson I. Limb salvage for soft-tissue sarcomas of the foot and ankle. J Bone Joint Surg Br. 2010;92(3):424–429.
   PubMedGoogle Scholar
• Gustafson P. Soft tissue sarcoma. Epidemiology and prognosis in 508 patients. Acta Orthop Scand Suppl. 1994;259:1–31.
   PubMedGoogle Scholar
• Lurkin A, Ducimetiere F, Vince DR, et al. Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region. BMC Cancer. 2010;10(1):150. .
   PubMed Web of Science ®Google Scholar
• Ray-Coquard I, Montesco MC, Coindre JM, et al. Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions. Ann Oncol. 2012;23(9):2442–2449. .
   PubMed Web of Science ®Google Scholar
• Ducimetiere F, Lurkin A, Ranchere-Vince D, et al. Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing. PLoS One. 2011;6(8):e20294. .
   PubMed Web of Science ®Google Scholar
• Perrier L, Rascle P, Morelle M, et al. The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: the experiences of the pathologists of the French Sarcoma Group. PLoS One. 2018;13(4):e0193330. .
   PubMed Web of Science ®Google Scholar
• Guillou L, Coindre JM, Bonichon F, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol. 1997;15(1):350–362. .
   PubMed Web of Science ®Google Scholar
• Cates JMM. The AJCC 8th edition staging system for soft tissue sarcoma of the extremities or trunk: a cohort study of the SEER database. J Natl Compr Canc Netw. 2018;16(2):144–152.
   PubMed Web of Science ®Google Scholar
• Ramanathan RC, A’Hern R, Fisher C, et al. Modified staging system for extremity soft tissue sarcomas. Ann Surg Oncol. 1999;6(1):57–69.
   PubMed Web of Science ®Google Scholar
• Amin M, Edge S, Greene F, et al. editors. AJCC Cancer Staging Manual. 8th ed. Springer International Publishing: American Joint Commission on Cancer; 2017.
   Google Scholar
• Mankin HJ, Mankin CJ, Simon MA. The hazards of the biopsy, revisited. Members of the musculoskeletal tumor society. J Bone Joint Surg Am. 1996;78(5):656–663.
   PubMed Web of Science ®Google Scholar
• Mankin HJ, Lange TA, Spanier SS. THE CLASSIC: the hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. The Journal of Bone and Joint Surgery, 1982;64:1121-1127. Clin Orthop Relat Res. 2006;450:4–10.
   PubMed Web of Science ®Google Scholar
• Mankin HJ, Lange TA, Spanier SS. The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. J Bone Joint Surg Am. 1982;64(8):1121–1127.
   PubMed Web of Science ®Google Scholar
• Neuville A, Ranchere-Vince D, Dei Tos AP, et al. Impact of molecular analysis on the final sarcoma diagnosis: a study on 763 cases collected during a European epidemiological study. Am J Surg Pathol. 2013;37(8):1259–1268. .
   PubMed Web of Science ®Google Scholar
• Schaefer IM, Cote GM, Hornick JL. Contemporary sarcoma diagnosis, genetics, and genomics. J Clin Oncol. 2018;36(2):101–110.
   PubMed Web of Science ®Google Scholar
• Cree IA, Deans Z, Ligtenberg MJ, et al. Guidance for laboratories performing molecular pathology for cancer patients. J Clin Pathol. 2014;67(11):923–931. .
   PubMed Web of Science ®Google Scholar
• Abarca T, Gao Y, Monga V, et al. Improved survival for extremity soft tissue sarcoma treated in high-volume facilities. J Surg Oncol. 2018;117(7):1479–1486.
   PubMed Web of Science ®Google Scholar
• Lazarides AL, Kerr DL, Nussbaum DP, et al. Soft tissue sarcoma of the extremities: what is the value of treating at high-volume centers? Clin Orthop Relat Res. 2019;477(4):718–727. .
   PubMed Web of Science ®Google Scholar
• Venigalla S, Nead KT, Sebro R, et al. Association between treatment at high-volume facilities and improved overall survival in soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 2018;100(4):1004–1015. .
   PubMed Web of Science ®Google Scholar
• Lindberg RD, Martin RG, Romsdahl MM, et al. Conservative surgery and postoperative radiotherapy in 300 adults with soft-tissue sarcomas. Cancer. 1981;47(10):2391–2397.
   PubMed Web of Science ®Google Scholar
• Leibel SA, Tranbaugh RF, Wara WM, et al. Soft tissue sarcomas of the extremities: survival and patterns of failure with conservative surgery and postoperative irradiation compared to surgery alone. Cancer. 1982;50(6):1076–1083.
   PubMed Web of Science ®Google Scholar
• Morii T, Tajima T, Honya K, et al. Clinical significance of the tail-like pattern in soft-tissue sarcomas on magnetic resonance imaging. J Orthop Sci. 2018;23(6):1032–1037.
   PubMed Web of Science ®Google Scholar
• De La Hoz Polo M, Dick E, Bhumbra R, et al. Surgical considerations when reporting MRI studies of soft tissue sarcoma of the limbs. Skeletal Radiol. 2017;46(12):1667–1678.
   PubMed Web of Science ®Google Scholar
• Davis LA, Dandachli F, Turcotte R, et al. Limb-sparing surgery with vascular reconstruction for malignant lower extremity soft tissue sarcoma. J Vasc Surg. 2017;65(1):151–156.
   PubMed Web of Science ®Google Scholar
• Bridgham KM, El Abiad JM, Lu ZA, et al. Reconstructive limb-salvage surgery after lower extremity soft tissue sarcoma resection: A 20-year experience. J Surg Oncol. 2019;119(6):708–716. .
   PubMed Web of Science ®Google Scholar
• Serletti JM, Carras AJ, O’Keefe RJ, et al. Functional outcome after soft-tissue reconstruction for limb salvage after sarcoma surgery. Plast Reconstr Surg. 1998;102(5):1576–1583. discussion 1584-1575. .
   PubMed Web of Science ®Google Scholar
• Wilke B, Cooper A, Scarborough M, et al. Comparison of limb salvage versus amputation for nonmetastatic sarcomas using patient-reported outcomes measurement information system outcomes. J Am Acad Orthop Surg. 2019;27(8):e381–e389.
   PubMed Web of Science ®Google Scholar
• Smith HG, Thomas JM, Smith MJF, et al. Major amputations for extremity soft-tissue sarcoma. Ann Surg Oncol. 2018;25(2):387–393.
   PubMed Web of Science ®Google Scholar
• Kainhofer V, Smolle MA, Szkandera J, et al. The width of resection margins influences local recurrence in soft tissue sarcoma patients. Eur J Surg Oncol. 2016;42(6):899–906. .
   PubMed Web of Science ®Google Scholar
• Potter BK, Hwang PF, Forsberg JA, et al. Impact of margin status and local recurrence on soft-tissue sarcoma outcomes. J Bone Joint Surg Am. 2013;95(20):e151. .
   PubMed Web of Science ®Google Scholar
• Gundle KR, Kafchinski L, Gupta S, et al. Analysis of margin classification systems for assessing the risk of local recurrence after soft tissue sarcoma resection. J Clin Oncol. 2018;36(7):704–709. .
   PubMed Web of Science ®Google Scholar
• Gronchi A, Miceli R, Fiore M, et al. Extremity soft tissue sarcoma: adding to the prognostic meaning of local failure. Ann Surg Oncol. 2007;14(5):1583–1590. .
   PubMed Web of Science ®Google Scholar
• Dickinson IC, Whitwell DJ, Battistuta D, et al. Surgical margin and its influence on survival in soft tissue sarcoma. ANZ J Surg. 2006;76(3):104–109. .
   PubMed Web of Science ®Google Scholar
• Endo M, Lin PP. Surgical margins in the management of extremity soft tissue sarcoma. Chin Clin Oncol. 2018;7(4):37.
   PubMed Web of Science ®Google Scholar
• Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998;16(1):197–203. .
   PubMed Web of Science ®Google Scholar
• Pisters PW, Harrison LB, Leung DH, et al. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol. 1996;14(3):859–868.
   PubMed Web of Science ®Google Scholar
• Haas RL, Delaney TF, O’Sullivan B, et al. Radiotherapy for management of extremity soft tissue sarcomas: why, when, and where? Int J Radiat Oncol Biol Phys. 2012;84(3):572–580. .
   PubMed Web of Science ®Google Scholar
• Karasek K, Constine LS, Rosier R. Sarcoma therapy: functional outcome and relationship to treatment parameters. Int J Radiat Oncol Biol Phys. 1992;24(4):651–656.
   PubMed Web of Science ®Google Scholar
• Nielsen OS, Cummings B, O’Sullivan B, et al. Preoperative and postoperative irradiation of soft tissue sarcomas: effect of radiation field size. Int J Radiat Oncol Biol Phys. 1991;21(6):1595–1599.
   PubMed Web of Science ®Google Scholar
• Wilson AN, Davis A, Bell RS, et al. Local control of soft tissue sarcoma of the extremity: the experience of a multidisciplinary sarcoma group with definitive surgery and radiotherapy. Eur J Cancer. 1994;30A(6):746–751. .
   PubMed Web of Science ®Google Scholar
• Sadoski C, Suit HD, Rosenberg A, et al. Preoperative radiation, surgical margins, and local control of extremity sarcomas of soft tissues. J Surg Oncol. 1993;52(4):223–230.
   PubMed Web of Science ®Google Scholar
• O’Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2002;359(9325):2235–2241. .
   PubMed Web of Science ®Google Scholar
• Wang D, Zhang Q, Eisenberg BL, et al. Significant reduction of late toxicities in patients with extremity sarcoma treated with image-guided radiation therapy to a reduced target volume: results of radiation therapy oncology group RTOG-0630 trial. J Clin Oncol. 2015;33(20):2231–2238. .
   PubMed Web of Science ®Google Scholar
• O’Sullivan B, Griffin AM, Dickie CI, et al. Phase 2 study of preoperative image-guided intensity-modulated radiation therapy to reduce wound and combined modality morbidities in lower extremity soft tissue sarcoma. Cancer. 2013;119(10):1878–1884. .
   PubMed Web of Science ®Google Scholar
• Lahat G, Tuvin D, Wei C, et al. New perspectives for staging and prognosis in soft tissue sarcoma. Ann Surg Oncol. 2008;15(10):2739–2748. .
   PubMed Web of Science ®Google Scholar
• Stojadinovic A, Leung DH, Allen P, et al. Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables. J Clin Oncol. 2002;20(21):4344–4352.
   PubMed Web of Science ®Google Scholar
• Clark MA, Fisher C, Judson I, et al. Soft-tissue sarcomas in adults. N Engl J Med. 2005;353(7):701–711.
   PubMed Web of Science ®Google Scholar
• Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002;20(3):791–796.
   PubMed Web of Science ®Google Scholar
• Callegaro D, Miceli R, Bonvalot S, et al. Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres. Eur J Cancer. 2018;105:19–27.
   PubMed Web of Science ®Google Scholar
• Zagars GK, Ballo MT, Pisters PW, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer. 2003;97(10):2530–2543. .
   PubMed Web of Science ®Google Scholar
• Pervaiz N, Colterjohn N, Farrokhyar F, et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008;113(3):573–581.
   PubMed Web of Science ®Google Scholar
• Woll PJ, Reichardt P, Le Cesne A, et al. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncol. 2012;13(10):1045–1054. .
   PubMed Web of Science ®Google Scholar
• Pasquali S, Pizzamiglio S, Touati N, et al. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial. Eur J Cancer. 2019;109:51–60.
   PubMed Web of Science ®Google Scholar
• Frustaci S, Gherlinzoni F, De Paoli A, et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol. 2001;19(5):1238–1247. .
   PubMed Web of Science ®Google Scholar
• Gronchi A, Frustaci S, Mercuri M, et al. Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas: a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group. J Clin Oncol. 2012;30(8):850–856. .
   PubMed Web of Science ®Google Scholar
• Gronchi A, Palmerini E, Quagliuolo V, et al. Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: final results of a randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups. J Clin Oncol. 2020;38(19):2178–2186.
   PubMed Web of Science ®Google Scholar
• Parsons JA, Davis AM. Rehabilitation and quality-of-life issues in patients with extremity soft tissue sarcoma. Curr Treat Options Oncol. 2004;5(6):477–488.
   PubMedGoogle Scholar
• Oren R, Zagury A, Katzir O, et al. Principles of rehabilitation after limb-sparing surgery for cancer. In: Musculoskeletal cancer surgery. Dordrecht: Springer; 2004. p. 583–593.
   Google Scholar
• Tobias K, Gillis T. Rehabilitation of the sarcoma patient-enhancing the recovery and functioning of patients undergoing management for extremity soft tissue sarcomas. J Surg Oncol. 2015;111(5):615–621.
   PubMed Web of Science ®Google Scholar
• Michot A, Stoeckle E, Bannel JD, et al. The introduction of early patient rehabilitation in surgery of soft tissue sarcoma and its impact on post-operative outcome. Eur J Surg Oncol. 2015;41(12):1678–1684. .
   PubMed Web of Science ®Google Scholar
• Kawai A, Miyakawa T, Senda M, et al. Gait characteristics after limb-sparing surgery with sciatic nerve resection: a report of two cases. J Bone Joint Surg Am. 2002;84(2):264–268.
   PubMed Web of Science ®Google Scholar
• van der Krogt MM, Delp SL, Schwartz MH. How robust is human gait to muscle weakness? Gait Posture. 2012;36(1):113–119.
   PubMed Web of Science ®Google Scholar
• Okita Y, Tatematsu N, Nagai K, et al. Methodological approach to evaluate the effects of muscle removal on estimated muscle forces during walking in patients after resection of soft tissue sarcoma in the thigh. J Mech Med Biol. 2020;20(1):1950077. .
   Web of Science ®Google Scholar
• Kwong TN, Furtado S, Gerrand C. What do we know about survivorship after treatment for extremity sarcoma? A systematic review. Eur J Surg Oncol. 2014;40(9):1109–1124. .
   PubMed Web of Science ®Google Scholar
• Campbell KL, Winters-Stone KM, Wiskemann J, et al. Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. 2019;51(11):2375–2390. .
   PubMed Web of Science ®Google Scholar
• Segal R, Zwaal C, Green E, et al. Exercise for people with cancer: a clinical practice guideline. Curr Oncol. 2017;24(1):40–46. .
   PubMed Web of Science ®Google Scholar
• Hudson MM, Mertens AC, Yasui Y, et al. Health status of adult long-term survivors of childhood cancer: a report from the childhood cancer survivor study. JAMA. 2003;290(12):1583–1592.
   PubMed Web of Science ®Google Scholar
• Tang MH, Pan DJ, Castle DJ, et al. A systematic review of the recent quality of life studies in adult extremity sarcoma survivors. Sarcoma. 2012;171342:2012.
   Google Scholar
• Paredes T, Canavarro MC, Simoes MR. Anxiety and depression in sarcoma patients: emotional adjustment and its determinants in the different phases of disease. Eur J Oncol Nurs. 2011;15(1):73–79.
   PubMed Web of Science ®Google Scholar
• Colterjohn NR, Davis AM, O’Sullivan B, et al. Functional outcome in limb-salvage surgery for soft tissue tumours of the foot and ankle. Sarcoma. 1997;1(2):67–74.
   PubMedGoogle Scholar